XKR8 and neoplasm: While the increased immunogenic outcomes associated with loss of Xkr8 scramblase function can be rationalized by impaired efferocytosis and potential secondary necrosis and activation of DAMPs, the mechanisms by which tumor growth and immune activation in the TMEM16F KO E0771 cells are more elusive but nonetheless interesting.